Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Polycystic Ovary Syndrome × Probiotics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 4 Uterine Cervical Neoplasms 2 Chalazion 2 Breast Neoplasms 2 Stomach Neoplasms 1 Radiation Injuries 1 Polycystic Ovary Syndrome 1 Periampullary Carcinoma Nos 1 Pelvic Inflammatory Disease 1 Neoplasms 1 Mucositis 1 Malnutrition 1 Lung Neoplasms 1 Liver Cirrhosis 1 Inflammation 1 Endotoxemia 1 Diarrhea 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

Metformin 74 Clomiphene 27 Letrozole 18 Inositol 18 Chorionic Gonadotropin 11 Folic Acid 10 Exercise 9 drospirenone and ethinyl estradiol combination 8 High-Intensity Interval Training 8 Cholecalciferol 8 cetrorelix 7 Tablets 7 Ethinyl Estradiol 7 Contraceptives, Oral 7 Progesterone 6 Menotropins 6 follitropin alfa 5 Pioglitazone 5 Exenatide 5 Caloric Restriction 5 Triptorelin Pamoate 4 Spironolactone 4 Liraglutide 4 Glycoprotein Hormones, alpha Subunit 4 Diet 4 Cyproterone Acetate 4 follitropin beta 3 Vitamin D 3 Thioctic Acid 3 Surveys and Questionnaires 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04593459 2024-03-22

ProPCO-RCT

Medical University of Graz

Phase 4 Completed

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡